Pasteurellosis / Snuffles

Pasteurellosis, commonly known as snuffles, represents one of the most prevalent and clinically significant bacterial diseases affecting domestic rabbits worldwide. This condition is caused primarily by the bacterium Pasteurella multocida, an organism that has evolved to persist within rabbit populations with remarkable success. The colloquial term snuffles derives from the characteristic snuffling and sneezing sounds made by affected rabbits attempting to breathe through congested nasal passages. While the upper respiratory tract serves as the most common site of clinical disease, pasteurellosis can affect virtually any organ system, making it a truly systemic concern rather than simply a respiratory problem.

The epidemiology of Pasteurella infection in rabbits presents challenges for disease management and eradication. Studies suggest that a significant proportion of domestic rabbits carry P. multocida asymptomatically, with colonization rates varying widely depending on population and testing methodology. The organism typically resides in the nasal passages, pharynx, and conjunctivae of carrier rabbits, causing no clinical signs until host defenses become compromised. This carrier state allows the bacteria to spread silently through rabbit populations, with transmission occurring through direct contact, aerosol droplets, contaminated fomites, and vertical transmission from does to kits. The widespread nature of asymptomatic carriage makes elimination from multi-rabbit households or breeding operations extremely difficult.

Clinical pasteurellosis develops when the balance between bacterial presence and host immune control shifts in favor of the pathogen. Stress plays a pivotal role in this transition, with various stressors including environmental changes, social disruption, concurrent illness, nutritional deficiencies, temperature extremes, and transport potentially triggering active disease in previously asymptomatic carriers. Once clinical infection establishes, the bacteria can spread from the initial site to cause disease throughout the body. Respiratory manifestations dominate clinical presentations, but pasteurellosis can produce abscesses anywhere in the body, reproductive tract infections, otitis media leading to head tilt, conjunctivitis, subcutaneous abscesses, septicemia, and even death in severe cases.

Treatment of pasteurellosis requires commitment to extended antibiotic therapy with rabbit-safe medications, supportive care addressing immediate symptoms, and management of underlying factors that allowed clinical disease to develop. Many rabbits respond well to appropriate treatment, experiencing resolution of acute symptoms and return to normal quality of life. However, complete bacterial eradication proves elusive in most cases, with the organism persisting in protected sites and potentially causing recurrent disease when host defenses again become compromised. This characteristic pattern of apparent resolution followed by recurrence defines the management challenge of pasteurellosis in rabbits. A rabbit-savvy veterinarian with experience managing this common condition provides essential guidance for optimizing outcomes while maintaining realistic expectations.

Pasteurella multocida, a gram-negative bacterium, serves as the primary causative agent of pasteurellosis in rabbits. This organism exists in multiple serotypes and biotypes, with certain strains demonstrating enhanced virulence or tissue tropism. The bacterium possesses several virulence factors enabling it to colonize host tissues, evade immune responses, and cause disease. A polysaccharide capsule provides protection from phagocytosis, adhesins facilitate attachment to respiratory epithelium, and various toxins contribute to tissue damage and inflammatory responses. The evolutionary success of P. multocida in rabbits reflects sophisticated adaptation to this host species, allowing persistent colonization while retaining the capacity for pathogenic behavior when conditions favor bacterial multiplication.

Transmission of Pasteurella between rabbits occurs through multiple routes, facilitating spread within and between populations. Direct contact represents the primary transmission pathway, with nose-to-nose contact during social interaction efficiently transferring bacteria between animals. Respiratory droplets expelled during sneezing can travel short distances and be inhaled by nearby rabbits. Contaminated fomites including food dishes, water bottles, bedding, and handling equipment can harbor bacteria and transmit infection indirectly. Sexual transmission occurs during breeding, and infected does pass the organism to their offspring through contact during nursing. This vertical transmission ensures persistence of the bacterium in breeding populations across generations.

Environmental and management factors significantly influence whether exposed rabbits develop clinical disease. Overcrowding increases both transmission opportunities and stress levels, creating conditions favoring active infection. Poor ventilation allows buildup of ammonia and bacteria in the air, irritating respiratory tissues and overwhelming mucosal defenses. Inadequate nutrition compromises immune function and reduces resistance to infection. Temperature extremes, particularly heat stress in summer or cold drafts in winter, stress the respiratory system. Sudden changes in diet, housing, or social groupings create stress that can trigger disease in carriers. Transport to new environments combines multiple stressors and frequently precipitates clinical pasteurellosis in previously healthy-appearing rabbits.

Host factors determine individual susceptibility to pasteurellosis once exposure occurs. Young rabbits, particularly those recently weaned and separated from their mothers, lack fully developed immune competence and experience significant stress, making them vulnerable to infection. Elderly rabbits with declining immune function may develop disease more readily than robust adults. Concurrent illness from any cause compromises defenses against opportunistic infections. Genetic factors likely influence immune response effectiveness, though specific susceptibility genes have not been well characterized in rabbits. Previous antibiotic treatment may have reduced bacterial load without achieving elimination, leaving residual populations ready to regrow when treatment stops.

The pathogenesis of clinical pasteurellosis begins with bacterial multiplication exceeding the host's capacity for immune control. In the upper respiratory tract, bacteria attach to epithelial cells and begin producing toxins that damage tissues and trigger inflammatory responses. The resulting inflammation produces the characteristic nasal discharge, sneezing, and congestion. From the nasal passages, infection can spread to adjacent structures including sinuses, tear ducts, and middle ear through the eustachian tubes. Hematogenous spread carries bacteria throughout the body, potentially establishing infection in distant sites including joints, reproductive organs, and subcutaneous tissues. The immune response to infection, while protective, also contributes to tissue damage and symptom production. This complex interplay between bacterial virulence and host response determines disease severity and outcome.

Early warning signs of pasteurellosis may be remarkably subtle, often overlooked until disease has progressed significantly. Initial indicators might include slightly increased sneezing frequency, minimal moisture around the nostrils noticed only on close inspection, or marginally reduced activity levels. The rabbit may show subtle changes in eating patterns, taking slightly longer to finish meals or showing mild preferences for softer foods. Fur on the inner aspect of the front paws may show early evidence of moisture from face washing. Because rabbits instinctively mask illness as a prey species survival mechanism, these early signs deserve attention rather than dismissal. By the time symptoms become obvious to casual observation, infection is often well established.

Classic respiratory symptoms of established snuffles include obvious nasal discharge ranging from clear and watery in early or mild cases to thick, white, or yellow-green as infection progresses. Frequent sneezing, sometimes in paroxysms of multiple consecutive sneezes, reflects irritation of nasal passages. Audible breathing sounds variously described as snuffling, snoring, or wheezing indicate nasal congestion and obstruction. Affected rabbits may breathe with visible effort, showing nostril flaring or elevated respiratory rate. Mouth breathing, while uncommon due to rabbits' obligate nasal breathing, indicates severe nasal obstruction and constitutes an emergency. Conjunctivitis with eye discharge frequently accompanies nasal symptoms due to the connection between tear ducts and nasal passages.

Behavioral changes reflect the rabbit's general malaise and physical discomfort from infection. Activity levels typically decrease, with affected rabbits preferring rest over normal exploration and play. Appetite often declines, creating serious risk of secondary GI stasis in a species that cannot tolerate prolonged reduction in food intake. Social behavior may change, with some rabbits seeking more contact while others withdraw from bonded partners and human family members. Grooming patterns often shift, with excessive face grooming or overall grooming reduction depending on how the rabbit feels. Sleep may be disrupted by breathing difficulty. Teeth grinding, a sign of pain in rabbits, may be audible. These behavioral changes often precede obvious physical symptoms and provide early warning for attentive owners.

Physical examination findings in pasteurellosis extend beyond respiratory signs depending on disease distribution. Nasal discharge with matted fur around the nostrils and on the front paws confirms active upper respiratory infection. Facial swelling suggests involvement of sinuses or development of abscesses. Head tilt indicates spread to the middle or inner ear causing vestibular dysfunction. Subcutaneous abscesses may develop as firm swellings anywhere on the body. Reproductive tract involvement may produce vaginal or preputial discharge. Eye involvement presents as redness, discharge, and prominence of the third eyelid. Lymph nodes may be enlarged, particularly those under the jaw. Weight loss develops with prolonged illness and reduced appetite.

Symptom progression in untreated pasteurellosis typically follows an escalating pattern, though the timeline varies considerably between individuals. Early mild symptoms worsen over days to weeks, with discharge becoming thicker and more purulent, sneezing more frequent, and general condition declining. Spread to additional body sites produces new symptoms specific to those locations. Pneumonia developing from lower respiratory tract involvement causes coughing, severe dyspnea, and rapid deterioration. Some rabbits develop chronic, fluctuating disease with periods of apparent improvement followed by flare-ups, rather than continuous linear progression. Septicemia, while uncommon, can cause rapid collapse and death.

Emergency symptoms requiring immediate veterinary care include severe respiratory distress with marked breathing difficulty or open-mouth breathing, which represents a dire emergency in rabbits. Collapse, extreme lethargy, or unresponsiveness indicates critical illness. Complete anorexia lasting more than twelve hours poses immediate risk of hepatic lipidosis and GI stasis. Sudden onset of severe head tilt suggests acute middle ear involvement. High fever with marked depression signals severe systemic illness. Any sudden dramatic worsening of previously stable symptoms warrants emergency evaluation. Because rabbits can deteriorate rapidly and hide the severity of their illness until crisis, owners should maintain low thresholds for seeking veterinary care when symptoms concern them.

Initial veterinary examination for suspected pasteurellosis involves comprehensive history taking and physical assessment by a rabbit-savvy veterinarian. History questions address symptom onset and progression, character of any discharge, sneezing frequency and pattern, appetite and activity changes, exposure to other rabbits, recent stressors including moves or new additions to the household, and any previous respiratory illness or treatment. Physical examination thoroughly evaluates the respiratory system including visual inspection of nostrils, assessment of discharge character, auscultation of lungs, and evaluation of respiratory rate and effort. Additional examination assesses for extra-respiratory manifestations including facial symmetry, eye involvement, ear canal health, lymph node enlargement, and presence of any masses or abscesses.

Laboratory diagnosis plays a central role in confirming pasteurellosis and guiding treatment decisions. Culture of nasal discharge or swabs from affected sites can identify Pasteurella multocida and other contributing bacteria. Antimicrobial sensitivity testing determines which antibiotics will effectively combat the specific bacterial isolates present, essential information given increasing antibiotic resistance patterns. Polymerase chain reaction testing offers more sensitive detection of Pasteurella DNA when culture proves difficult or when identifying asymptomatic carriers. Complete blood count may reveal elevated white blood cells indicating infection, and serum chemistry assesses overall organ function. Serological testing for antibodies against Pasteurella has been used in research settings but has limited clinical utility due to high rates of exposure in the general rabbit population.

Diagnostic imaging helps characterize disease extent and identify complications requiring specific treatment. Skull radiographs reveal sinus involvement, dental disease that may complicate respiratory infection, and bony changes from chronic infection. Thoracic radiographs assess for pneumonia or lower respiratory tract involvement. Computed tomography provides superior detail for complex cases, particularly those involving skull structures, sinuses, or ear bullae. Ultrasound may identify abscesses or fluid collections in accessible locations. The choice of imaging modalities depends on clinical presentation, with straightforward upper respiratory cases requiring less extensive workup than complex or treatment-resistant presentations.

Differential diagnosis considers other conditions producing similar symptoms. Other bacterial species including Bordetella, Staphylococcus, and Pseudomonas can cause respiratory infection with or without Pasteurella involvement. Viral infections, while less common primary respiratory pathogens in rabbits than bacteria, may predispose to secondary bacterial infection. Dental disease with tooth root involvement can produce nasal discharge and facial swelling mimicking or complicating pasteurellosis. Allergic rhinitis causes sneezing and discharge without necessarily involving bacterial infection. Nasal foreign bodies produce sneezing and typically unilateral discharge. Myxomatosis, where present, causes severe facial swelling and respiratory signs. Accurate diagnosis guides appropriate treatment selection and provides realistic prognostic information.

Immediate treatment priorities for rabbits presenting with acute pasteurellosis focus on stabilization and initiation of antimicrobial therapy. If significant respiratory distress is present, oxygen supplementation supports breathing while other treatments take effect. Clearing accumulated discharge from nostrils helps maintain nasal airflow in obligate nasal breathers. Fluid therapy addresses dehydration, supports mucus production, and helps thin respiratory secretions. If the rabbit is not eating, syringe feeding with critical care formula must begin immediately to prevent secondary GI stasis, which poses life-threatening risk in rabbits unable to tolerate even brief periods without food. Pain management with rabbit-safe anti-inflammatory medications such as meloxicam reduces discomfort and encourages normal eating and activity.

Antibiotic selection for pasteurellosis requires careful attention to both efficacy against Pasteurella and safety in rabbits. Enrofloxacin represents a commonly used first-line treatment with good activity against respiratory pathogens and favorable safety profile. Trimethoprim-sulfamethoxazole provides an effective alternative with good tissue penetration. Azithromycin offers another option with convenient once-daily dosing. Chloramphenicol may be used for resistant infections. Penicillin G injections can be effective, though oral penicillin and related antibiotics are contraindicated in rabbits due to fatal disruption of intestinal flora. Treatment duration typically extends four to six weeks or longer, substantially longer than antibiotic courses used in many other conditions. Premature discontinuation is the most common cause of relapse and contributes to development of antibiotic resistance.

Topical and adjunctive therapies supplement systemic antibiotic treatment. Nebulization delivers medication directly to respiratory tissues while helping moisturize and clear congested airways. Saline with or without antibiotics such as gentamicin can be nebulized for fifteen to twenty minutes several times daily. Eye medications address concurrent conjunctivitis. Cleaning accumulated discharge from the face helps maintain comfort and allows accurate symptom assessment. For rabbits with middle ear involvement causing head tilt, supportive care including safe housing preventing falls, hand feeding if needed, and sometimes vestibular suppressants support recovery. Abscesses may require surgical drainage or excision in addition to systemic antibiotics.

Supportive care requirements are extensive and critical to recovery from pasteurellosis. Nutritional support through syringe feeding maintains gastrointestinal function and provides energy for healing when appetite is reduced. Unlimited hay encourages gut motility and provides essential fiber. Fresh greens offer hydration and nutrition. Hydration must be actively maintained, with subcutaneous fluids administered if oral intake is inadequate. Gut motility support with medications like metoclopramide or cisapride may be needed if GI slowdown develops. Environmental optimization includes ensuring good ventilation without drafts, low-dust bedding, appropriate temperatures, and stress reduction through quiet housing. Separating ill rabbits from healthy herdmates reduces transmission, though if bonded pairs are involved, separation stress must be weighed against transmission risk.

Long-term management recognizes that complete eradication of Pasteurella rarely occurs. Many rabbits achieve clinical resolution with appropriate treatment but remain carriers susceptible to recurrence during future stress. Some require prolonged or intermittent antibiotic therapy to maintain control. A subset develops truly chronic disease requiring ongoing management rather than cure. Addressing underlying factors that precipitated clinical disease helps prevent recurrence. Stress reduction, environmental optimization, excellent nutrition, and prompt attention to any illness or injury reduce opportunities for bacterial regrowth. Regular veterinary monitoring enables early intervention when problems recur.

Treatment decisions involve balancing multiple factors including disease severity, extent of spread, response to initial therapy, owner commitment to extended treatment protocols, and financial considerations. Mild upper respiratory disease in otherwise healthy rabbits generally responds well to appropriate antibiotic courses with supportive care. Severe disease with systemic involvement or multiple affected sites requires more aggressive and prolonged treatment. Cases involving complications like pneumonia, severe abscesses, or middle ear disease present greater treatment challenges. Honest discussion with the veterinary team about likely outcomes, treatment requirements, and costs helps owners make informed decisions. The goal is maintaining acceptable quality of life, which remains achievable for many rabbits with pasteurellosis through appropriate management.

Recovery timeline from acute pasteurellosis varies based on disease severity, treatment promptness, and individual patient factors. Clinical improvement typically begins within the first week of appropriate antibiotic therapy, with decreasing discharge, reduced sneezing, improving appetite, and increased activity. However, antibiotics must continue for the full prescribed course of four to six weeks or longer regardless of apparent clinical resolution. Premature discontinuation allows residual bacterial populations to regrow, causing relapse and potentially developing antibiotic resistance. Complete resolution of visible symptoms may take several weeks, with some improvement continuing even after antibiotic completion as inflammation subsides and tissues heal.

Post-treatment care focuses on preventing relapse and monitoring for recurrence. Follow-up veterinary examinations assess treatment response and guide decisions about continuing or modifying therapy. Environmental factors that may have contributed to disease development should be addressed, including improving ventilation, reducing dust exposure, and minimizing stress. Excellent nutrition supports immune function and overall health during recovery. Close observation for any return of respiratory symptoms enables early intervention if relapse occurs. Maintaining separation from non-exposed rabbits reduces transmission risk, though the practicality of permanent isolation in multi-rabbit households is limited given the endemic nature of Pasteurella in domestic rabbits.

Prognosis for pasteurellosis depends on multiple factors affecting likelihood of successful management. Rabbits with localized upper respiratory disease diagnosed and treated early have good prognosis for clinical resolution, though carrier status typically persists. Young, otherwise healthy rabbits generally respond better than elderly or immunocompromised individuals. Cases involving complications like pneumonia, extensive abscessation, or middle ear disease carry more guarded prognosis. Antibiotic-resistant infections present treatment challenges and worse outcomes. Chronic cases that have failed multiple treatment attempts may never achieve stable resolution. Despite these variables, many rabbits with pasteurellosis live comfortable lives with appropriate management.

Long-term outlook must acknowledge the typically chronic nature of Pasteurella infection in rabbits. Most treated rabbits remain carriers even after clinical resolution, with the organism persisting in protected tissue sites. Future stress episodes may precipitate recurrence, requiring additional treatment. Some rabbits experience periodic flare-ups throughout life, manageable with prompt intervention but not curable. Others achieve stable long-term resolution with only occasional minor symptoms. Monitoring for recurrence, prompt treatment when needed, stress minimization, and excellent husbandry practices optimize long-term outcomes. While complete cure is rarely achieved, acceptable quality of life remains achievable for most rabbits with pasteurellosis through committed management.

Primary prevention of pasteurellosis focuses on reducing pathogen exposure and maintaining conditions that support immune function. Quarantine of new rabbits before introduction to resident animals is essential, with isolation for at least two to four weeks and veterinary examination to identify potential problems. Testing new rabbits for Pasteurella carriage through nasal culture or PCR can identify infected animals, though test limitations and the high prevalence of asymptomatic carriage complicate interpretation. Avoiding contact with rabbits of unknown health status at shows, fairs, or other events reduces exposure to potentially infected animals. Maintaining closed populations where possible, with careful screening of any additions, limits introduction of new strains.

Environmental management significantly reduces pasteurellosis risk by minimizing stressors and optimizing respiratory health. Adequate ventilation prevents ammonia accumulation and reduces airborne pathogen concentration while avoiding direct drafts on rabbits. Regular cleaning prevents buildup of waste products and contamination. Low-dust bedding materials reduce respiratory irritation that can compromise mucosal defenses. Temperature control avoids the stress of extremes, keeping environments below seventy-five degrees Fahrenheit and protecting from cold drafts. Appropriate space prevents overcrowding stress and reduces close contact transmission. Noise reduction and consistent routines minimize stress that can trigger disease in carriers.

Dietary factors supporting immune competence help rabbits resist infection. Unlimited grass hay must form the foundation of the diet, providing essential fiber for gut health, which closely links to immune function. Quality pellets in appropriate amounts provide balanced nutrition without excess calories. Fresh leafy greens daily offer variety and additional nutrients. Avoiding sugary treats and high-starch foods maintains stable gut flora and metabolic function. Clean, fresh water always available ensures adequate hydration for healthy mucus production. Consistent diet without sudden changes prevents gastrointestinal disruption that can stress the immune system.

Health maintenance through regular veterinary care identifies problems early and optimizes overall condition. Annual or semi-annual wellness examinations with a rabbit-savvy veterinarian allow professional assessment and early detection of developing issues. Dental health monitoring is particularly important as dental disease can predispose to respiratory problems. Weight management prevents obesity-related immune compromise. Appropriate parasite prevention reduces systemic stress. Spaying females prevents reproductive tract pasteurellosis and associated health benefits. Any illness or injury should receive prompt attention to prevent stress from triggering respiratory flare-ups in carriers.

Early intervention when symptoms appear prevents progression to serious disease. Rabbit owners should recognize that sneezing, nasal discharge, and respiratory sounds warrant prompt veterinary attention rather than wait-and-see approaches. Subtle changes in behavior or eating may indicate early infection. Starting appropriate treatment before disease becomes established in multiple sites improves treatment success. Following antibiotic courses completely, even after symptoms resolve, prevents relapse and resistance development. Environmental assessment and modification address contributing factors. Because many rabbits are asymptomatic carriers, owners should understand that exposure does not guarantee disease, but vigilance enables early detection and intervention when clinical infection develops.

Daily management of a rabbit with pasteurellosis requires consistent monitoring and environmental attention. Observe respiratory status daily, noting discharge amount and character, sneezing frequency, and breathing comfort. Track food and water intake carefully, as decreased eating can rapidly cascade into dangerous GI stasis. Check litter box output to ensure gastrointestinal function remains normal, watching for changes in fecal pellet size, quantity, or consistency. Administer medications on schedule using appropriate techniques for medicating rabbits, which may include hiding medications in favorite foods, syringe administration, or other methods suited to the individual. Clean accumulated discharge from the face and nostrils gently to maintain comfort and allow accurate symptom assessment.

Home environment optimization supports respiratory health and reduces recurrence risk. Ventilation must provide fresh air circulation while protecting from drafts. Bedding should be changed frequently, using low-dust materials like paper-based products rather than shavings that can irritate respiratory tissues. Hay quality matters, with preference for second-cut timothy or other low-dust varieties, properly stored and shaken before offering to minimize particle inhalation. Air purifiers with HEPA filters can reduce airborne irritants in the rabbit's living area. Temperature should remain moderate, ideally below seventy-five degrees Fahrenheit, as heat stress compounds respiratory difficulty. Quiet, low-stress location reduces anxiety that can trigger symptom flare-ups.

Quality of life assessment guides ongoing management decisions and helps determine treatment intensity. Signs indicating acceptable quality of life include maintained interest in food and treats, willingness to engage with bonded partners or family members, normal grooming behavior, comfortable rest positions, and general contentment despite chronic disease. Warning signs of declining quality include persistent severe respiratory distress unresponsive to treatment, complete loss of appetite requiring constant forced feeding, complete withdrawal from all interaction, inability to rest comfortably, and apparent suffering. Honest evaluation in partnership with the veterinary team helps balance continued treatment against comfort-focused care when appropriate.

Monitoring and ongoing veterinary care enable early intervention for flare-ups and complications. Regular veterinary check-ups, frequency depending on disease stability, assess overall condition and guide medication decisions. Between visits, watch for symptom changes suggesting relapse or progression, including increased discharge, more frequent sneezing, worsening breathing, or new symptoms in different body areas. Weight monitoring through weekly weigh-ins detects trends that might indicate problems. Keeping a simple log of observations provides valuable information for veterinary consultations. Communication with the veterinary team about any concerns enables timely guidance and prevents minor issues from becoming major problems.

Caregiver support resources help rabbit owners manage the challenges of long-term pasteurellosis care. Chronic disease management requires sustained commitment to medication schedules, environmental maintenance, and vigilant monitoring. Online communities including House Rabbit Society forums connect owners facing similar challenges. Local rabbit rescue groups may offer practical advice and emotional support. Financial planning for ongoing veterinary costs helps reduce stress, as chronic disease management can be expensive. Acknowledging the emotional toll of caring for a chronically ill pet validates the caregiver's experience. When difficult decisions approach, veterinary guidance helps balance treatment options with quality of life considerations. Support networks sustain caregivers through the long-term commitment required for successful pasteurellosis management.

Pasteurellosis affects all rabbit breeds without clear breed-specific predisposition to infection itself. The bacterium Pasteurella multocida colonizes rabbit populations broadly, with carriage rates varying more by population exposure than by breed genetics. However, certain breeds may experience more severe respiratory symptoms or complications due to anatomical factors affecting their respiratory systems. Lop-eared breeds including Holland Lops, Mini Lops, English Lops, and French Lops may have altered skull conformation affecting sinus drainage and nasal structure, potentially complicating respiratory infections. Dwarf breeds including Netherland Dwarfs, Dwarf Hotots, and Polish rabbits often have brachycephalic facial features that compress nasal passages.

Beyond breed-specific anatomical factors, certain categories of rabbits face elevated risk of developing clinical pasteurellosis. Young rabbits, particularly recently weaned kits experiencing the stress of separation and environmental transition, are highly susceptible to initial infection and clinical disease. Elderly rabbits with declining immune function may develop disease more readily than robust adults. Rabbits from crowded environments including pet stores, breeding facilities, and rescue situations often carry heavy bacterial loads and have experienced stress promoting active infection. Rabbits with concurrent health problems, particularly dental disease, face compounded respiratory risk. Unspayed female rabbits experience hormonal stress and may develop reproductive tract pasteurellosis.

Screening recommendations for pasteurellosis recognize both the limitations of testing and the value of early detection. All new rabbits should undergo veterinary examination and ideally quarantine before introduction to resident animals. Nasal culture or PCR testing can identify Pasteurella carriers, though negative results do not guarantee absence and positive results are common in the general population. Rabbits from high-risk sources warrant particular attention. Any rabbit showing respiratory symptoms should receive prompt veterinary evaluation rather than watchful waiting. Breeding animals may be screened to reduce vertical transmission to offspring, though eradication from breeding colonies proves extremely difficult. Understanding that most domestic rabbits are likely carriers helps focus prevention efforts on maintaining conditions that prevent clinical disease rather than attempting impossible elimination.

Commonly co-occurring conditions with pasteurellosis reflect the systemic nature of Pasteurella infection and its potential to affect multiple body systems. Conjunctivitis frequently accompanies upper respiratory infection due to the anatomical connection between nasal passages and tear ducts. Otitis media, middle ear infection, develops when bacteria spread through eustachian tubes, potentially causing head tilt and vestibular signs. Sinusitis occurs when infection spreads to sinus cavities, producing facial swelling and more severe symptoms. Pneumonia represents serious lower respiratory tract involvement requiring aggressive treatment. Subcutaneous abscesses can develop anywhere on the body from hematogenous spread. Reproductive tract infections including pyometra and orchitis occur in intact animals. GI stasis commonly develops secondary to reduced appetite and illness stress, representing a life-threatening complication requiring aggressive management.

Conditions with similar symptoms require differentiation from pasteurellosis for appropriate treatment. Other bacterial respiratory infections including Bordetella bronchiseptica and Staphylococcus species can produce similar upper respiratory symptoms. Dental disease with tooth root involvement can cause nasal discharge, facial swelling, and general illness mimicking or complicating pasteurellosis. Allergic rhinitis produces sneezing and discharge without bacterial infection, requiring different management. Myxomatosis, where present, causes severe facial swelling and respiratory compromise. Thymoma and other thoracic masses can cause respiratory symptoms in older rabbits. Encephalitozoon cuniculi can cause head tilt similar to middle ear pasteurellosis. Accurate diagnosis ensures appropriate treatment selection.

Potential complications from pasteurellosis extend throughout the body and may require specific management attention. Osteomyelitis develops when chronic infection spreads to bone, particularly in skull structures, creating extremely difficult treatment challenges. Brain abscessation can occur in severe cases with devastating consequences. Septicemia, while uncommon, causes rapid deterioration and may be fatal. Chronic respiratory damage from prolonged infection can create permanent compromise. Secondary hepatic lipidosis develops if prolonged anorexia occurs. GI stasis from reduced food intake poses immediate life-threatening risk in rabbits. Recognition of potential complications guides proactive monitoring and enables early intervention to preserve the rabbit's health and quality of life.